“BUY” This Large Cap Retail Stock With A Target Price of Rs. 340: Emkay Global

The brokerage’s take on Aditya Birla Fashion & Retail Ltd.

Emkay Global has commented in its research report that “In terms of Q2 recovery, we note that ABFRL led the pack with an impressive per-store recovery of ~110% for Lifestyle business vs. 70-80% recovery for peers. Recovery in Pantaloons has also been strong at ~100% in the festive season, with the opening up of malls and upbeat consumer sentiment.

According to the brokerage’s research report “ABFRL’s overall growth in Q2 was impacted by the weak wholesale channel due to lower stocking by MBO/LFS. In our view, recovery in this channel, coupled with strong festive demand, can boost growth in H2. Store additions were muted in H1 vs. 5-10% network expansion seen by V-Mart/Trent. The slower additions were due to operating challenges and ongoing renovations for Pantaloons. However, store additions are expected to pick up with ~100 stores for Ethnic in the next 12 months and ~60/250 net-new additions for Pantaloons/Lifestyle in FY22. Overall CAPEX is expected to be in the range of Rs4bn.”

The brokerage has also claimed that the company’s “Ethnic and innerwear account for ~40% of India’s apparel industry (USD67bn in FY20). In our view, with these new segments, ABFRL now has the most diversified portfolio among peers, addressing 75-80% of the overall apparel opportunity. The growth opportunity in the Ethnic category is yet to play out. Management has robust growth plans in this space, which can surprise ahead.”

Buy Aditya Birla Fashion & Retail Ltd. With A Target Price of Rs. 340

According to the brokerage’s call “Strong demand trends, aggressive portfolio/store expansion and improving efficiencies keep us positive. After the recent 10% correction, valuations at ~25x Dec’23E pre-IndAS EBITDA are at a discount to peers. Further, the expansion into Tier-2/3/4 cities with Pantaloons/PE-Red/AS-Prime and traction in the Ethnic category should help sustain high-teen earnings growth well beyond FY24. Reiterate Buy with a TP of Rs340 (30x Dec’23E pre-IndAS EBITDA). The emergence of a third Covid wave remains a key risk to our estimates.”

Disclaimer

The stock has been picked from the brokerage report of Emkay Global Financial Services Limited. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution. Greynium Information Technologies, the author, and the brokerage house are not liable for any losses caused as a result of decisions based on the article.